JR14a
Product Specifications
UNSPSC Description
JR14a is a potent thiophene antagonist of human complement C3a receptor. JR14a shows selectivity for the human C3a receptor over C5a receptor. JR14a can suppress C3aR-mediated inflammation[1].
Target Antigen
Complement System
Type
Reference compound
Related Pathways
Immunology/Inflammation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jr14a.html
Smiles
O=C(C(SC(C(C(C=C1)=CC=C1Cl)C(C=C2)=CC=C2Cl)=C3)=C3C)N[C@H](C(O)=O)CCCNC(N)=N
Molecular Weight
533.47
References & Citations
[1]Rowley JA, et, al. Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity. J Med Chem. 2020 Jan 23;63(2):529-541.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-138161/JR14a-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-138161/JR14a-SDS-MedChemExpress.pdf
CAS Number
2411440-41-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Fmoc-L-glutamic acid-gamma-[beta-(5-naphthyl sulfonic acid)-ethylenediamine] ester](https://cdn.genprice.uk/genprice/genprice5.png)
sc-285776 100 mg
Fmoc-L-glutamic acid-gamma-[beta-(5-naphthyl sulfonic acid)-ethylenediamine] ester
Ask
View Details ![Human Monoclonal Integrin alpha V/CD51 Antibody (abituzumab) [Janelia Fluor 525]](https://cdn.genprice.uk/genprice/genprice2.png)
NBP3-28527JF525 0.1 mL
Human Monoclonal Integrin alpha V/CD51 Antibody (abituzumab) [Janelia Fluor 525]
Ask
View Details 